Clinical Trial Update: The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care [NA]

View source ↗

Summary

The SUSTAIN 2 trial is studying sustained HIV treatment adherence after interruption in care, with recruitment ongoing at Brigham and Women's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Human Immunodeficiency Virus | NA | Status: RECRUITING